RBC Capital analyst Nik Modi raised the firm’s price target on Clorox to $151 from $137 and keeps a Sector Perform rating on the shares. The company’s Q3 earnings beat was "impressive" with gross margin expansion and increased guidance, the analyst tells investors in a research note. Clorox has faced a multitude of headwinds during and exiting the pandemic that will still take a few more quarters to work through, but things are getting "less bad" across most of its businesses, RBC added.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLX: